Universal Health Services’ third quarter results were met with a negative market reaction, despite the company meeting Wall Street’s revenue expectations and modestly exceeding non-GAAP profit estimates. Management cited sequential improvement in acute care demand and increased behavioral health volumes, alongside continued moderation in labor costs. However, CEO Marc Miller acknowledged that a slower-than-expected ramp-up at new hospitals and softness in surgical trends weighed on overall performance. CFO Steve Filton noted, “The shortfall primarily reflected a slower than expected ramp-up at our de novo hospitals and softer than expected surgical trends,” emphasizing the impact of shifts in service mix and ongoing integration efforts.

Is now the time to buy UHS? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from Universal Health Services’s Q3 earnings call

• AJ Rice (UBS) asked about 2027 headwinds from Medicaid supplemental payments and exchange enrollment. CFO Steve Filton explained that the largest swing factors will be facility ramp-ups and regulatory changes, with estimated $175–$200 million in reduced supplemental payments.
• Ann Hynes (Mizuho) inquired about the slow ramp at new acute care hospitals. Filton attributed delays at Cedar Hill to physician infrastructure shortages and at Palm Beach Gardens to seasonal timing, stating both are expected to improve but at a gradual pace.
• Matthew Gillmor (KeyBanc) asked about labor trends and Talkspace integration. Filton highlighted reduced contract labor and slowing wage growth, and reiterated that Talkspace synergies will be realized over 12–24 months, mainly through improved continuum of care.
• Stephen Baxter (Wells Fargo) questioned margin pressure from surgical mix changes. Filton clarified that a shift toward medical admissions was not intentional and that management continues to invest in procedural volume growth through technology and outpatient access points.
• Sarah James (Cantor Fitzgerald) asked about proof of concept for Talkspace integration. Filton responded that increased outpatient activity at both Talkspace and UHS, especially through cross-referrals, will be a key metric to assess integration success.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be watching (1) the pace of patient volume and margin recovery at new and recently expanded acute care facilities, (2) operational progress and recertification at Laurel Ridge Treatment Center, and (3) the effectiveness of the Talkspace integration in accelerating outpatient behavioral health growth. Additional focus will be placed on managing regulatory headwinds and the evolution of payer mix.

Universal Health Services currently trades at $172.49, down from $177.33 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

High-quality stocks for all market conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.